Reduced expression levels of the death‑associated protein kinase and E-cadherin are correlated with the development of esophageal squamous cell carcinoma

Deiss LP, Feinstein E, Berissi H, Cohen O and Kimchi A: Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators ofthe gamma interferon-induced cell death. Genes Dev. 9:15–30. 1995. View Article : Google Scholar

Brabender J, Arbab D, Huan X, et al: Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Ann Surg Oncol. 16:1378–1383. 2009. View Article : Google Scholar : PubMed/NCBI

Tong A, Lynn G, Ngo V, et al: Negative regulation of Caenorhabditis elegans epidermal damage responses by death-associated protein kinase. Proc Natl Acad Sci USA. 106:1457–1461. 2009.

Li H, Ray G, Yoo BH, Erdogan M and Rosen KV: Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells. Biol Chem. 284:2012–2022. 2009. View Article : Google Scholar : PubMed/NCBI

Zalckvar E, Berissi H, Eisenstein M and Kimchi A: Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy. 5:720–722. 2009. View Article : Google Scholar : PubMed/NCBI

Yanagawa N, Osakabe M, Hayashi M, Tamura G and Motoyama T: Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int. 58:477–482. 2008. View Article : Google Scholar : PubMed/NCBI

Hoffmann AC, Vallböhmer D, Prenzel K, et al: Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol. 135:1231–1237. 2009. View Article : Google Scholar : PubMed/NCBI

Fendri A, Masmoudi A, Khabir A, et al: Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Cancer Biol Ther. 8:444–451. 2009. View Article : Google Scholar : PubMed/NCBI

Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, et al: E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 11:E100–E105. 2006.

Zhai JW, Yang XG, Yang FS, Hu JG and Hua WX: Expression and clinical significance of Ezrin and E-cadherin in esophageal squamous cell carcinoma. Chin J Cancer. 29:317–320. 2010. View Article : Google Scholar : PubMed/NCBI

Gao DL, Li SL, Chen KS, Zhao ZH, Zhao QM, Liu ZW and Zhang YH: The inhibition of metalloproteinase in RECK expression in esophageal squamous cell carcinoma and its biological significance. World J Gastroenterol. 16:1634–1638. 2008.

Gonzalez MA, Pinder SE, Wencyk PM, et al: An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and betal-integrins in invasive breast cancer. J Pathol. 187:523–529. 1999. View Article : Google Scholar

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL and Du Z: Aberrant methylation of multiple genes and its clinical implication in hepatocellularcarcinoma. Zhonghua Zhong Liu Za Zhi. 30:831–836. 2008.(In Chinese).

Bajbouj K, Poehlmann A, Kuester D, et al: Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apoptosis in colorectal tumor cells. Am J Pathol. 175:557–570. 2009. View Article : Google Scholar : PubMed/NCBI